Fiche centre
Ospedale San Bortolo
Vicenza — Italy
Essais liés3clinical trials
VilleVicenzalocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06531824
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| BI 690517 | Maladie rénale chronique | Phase 3 | NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | ACTIVE_NOT_RECRUITING |
| IMPACT STREAM — Master Framework For Relapse or Refractory Acute Myeloid Leukemia | Cancer | À vérifier | NCT06459024 | IMPACT STREAM — Master Framework For Relapse or Refractory Acute Myeloid Leukemia | RECRUITING |
| BLESS — Cenobamate in Adults With Focal-Onset Seizures | Épilepsie | À vérifier | NCT05859854 | BLESS — Cenobamate in Adults With Focal-Onset Seizures | ACTIVE_NOT_RECRUITING |